Clinical Trials Logo

Base of the Tongue Carcinoma clinical trials

View clinical trials related to Base of the Tongue Carcinoma.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04277858 Recruiting - Oropharynx Cancer Clinical Trials

Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.

NECTORS
Start date: August 14, 2018
Phase: Phase 2
Study type: Interventional

The objective of this trial is to study the efficacy of treatment of human papilloma virus (HPV) related oropharyngeal cancer with chemotherapy followed by Transoral Robotic Surgery (TORS) as definitive treatment. Current treatment of oropharyngeal cancer are chemo-radiotherapy. There is significant lifelong side effects associated with this approach related to tissue effects of radiotherapy. The side effects results in significant quality of life deterioration among the patients. Overall there is 20% failure rate with this treatment approach. The study hypothesis is that treatment with upfront (neoadjuvant) chemotherapy followed by transoral surgery and neck dissection is highly effective treatment allowing competitive cure rate compared to chemo-radiotherapy with less than 10% failure rate, while avoiding radiotherapy in majority of cases. It is also hypothesized that better functional and quality of life outcome maybe achieved with this approach.